TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Astrazeneca AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
733,922
|
678,257
|
570,318 |
Financial expenses |
832
|
618
|
507 |
Earnings before taxes |
35,522
|
27,240
|
15,174 |
Total assets |
506,865
|
502,414
|
434,278 |
Current assets |
504,900
|
500,920
|
432,596 |
Current liabilities |
113,204
|
108,398
|
70,535 |
Equity capital |
392,911
|
394,016
|
361,405 |
- share capital |
113,570
|
121,629
|
117,973 |
Employees (average) | 86 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.5%
|
78.4%
|
83.2% |
Turnover per employee | 7,887 | ||
Profit as a percentage of turnover |
4.8%
|
4.0%
|
2.7% |
Return on assets (ROA) |
7.2%
|
5.5%
|
3.6% |
Current ratio |
446.0%
|
462.1%
|
613.3% |
Return on equity (ROE) |
9.0%
|
6.9%
|
4.2% |
Change turnover |
100,603
|
90,267
|
-28,185 |
Change turnover % |
16%
|
15%
|
-5% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.